University Department of Adult Psychiatry, 26905CHU Montpellier, University Montpellier 1, Hôpital la Colombière, France.
27038Université Paul Valéry Montpellier 3, EPSYLON EA, France.
Can J Psychiatry. 2021 Apr;66(4):395-405. doi: 10.1177/0706743720966443. Epub 2020 Oct 16.
Assessing an individual's capacity to consent to treatment is a complex and challenging task for psychiatrists and health-care professionals. Diminished capacity to consent to pharmacological treatment is a common concern in individuals with schizophrenia. The MacArthur Competence Assessment Tool for Treatment (MacCAT-T) is the most common tool used in individuals with schizophrenia to evaluate the decision-making abilities for judgments about competence to consent to treatment. This instrument assesses patients' competence to make treatment decisions by examining their capacities in 4 areas: understanding information relevant to their condition and the recommended treatment, reasoning about the potential risks and benefits of their choices, appreciating the nature of their situation and the consequences of their choices, and expressing a choice. Despite its importance, there is no French version of this scale. Furthermore, its factor structure has never been explored, although validated measures are strongly needed to further detect deficits in patients' decision-making abilities. The goal of this study was thus to empirically validate a French version of the MacCAT-T in a French sample of individuals with schizophrenia.
In this cross-sectional study, we included 125 inpatients with a diagnosis of schizophrenia from the University Department of Adult Psychiatry in Montpellier. The MacCAT-T was administered to patients by a trained psychologist. Patients were also assessed for severity of symptoms, insight into illness, and depressive and anxiety symptoms. Inter-rater reliability and psychometric properties including internal consistency, construct validity, and discriminant and divergent validity were also investigated.
The MacCAT-T's internal consistency was high (Cronbach α of 0.91). A high degree of inter-rater reliability was found for all the areas of the MacCAT-T (intraclass correlation coefficient range, 0.92 to 0.98). Exploratory factor analysis revealed a 2-factor model. The factor analysis explained 50.03% of the total score variation. Component 1 included all subparts of "understanding." Component 2 included all subparts of "appreciation" and "reasoning" and was therefore labeled "reflexivity." After Bonferroni corrections, decision-making capacity was positively associated with insight and the severity of psychotic symptoms but not with sociodemographic variables except for education.
The MacCAT-T demonstrated a high degree of inter-rater reliability and strong psychometric properties. The French version of the MacCAT-T is a valid instrument to assess the decision-making capacity to consent to treatment in a French sample of individuals with schizophrenia.
评估个体是否有能力同意治疗是精神科医生和医疗保健专业人员的一项复杂而具有挑战性的任务。在精神分裂症患者中,同意药物治疗的能力下降是一个常见的问题。《麦克阿瑟治疗同意能力评估工具》(MacCAT-T)是评估精神分裂症患者同意治疗决策能力最常用的工具。该工具通过检查患者在以下 4 个方面的能力来评估他们的治疗决策能力:理解与病情和推荐治疗相关的信息、对选择的潜在风险和益处进行推理、认识自己的处境和选择的后果、表达选择。尽管它很重要,但该工具没有法语版本。此外,尽管需要经过验证的工具来进一步发现患者决策能力的缺陷,但它的因素结构从未被探索过。因此,本研究的目的是在法国精神分裂症患者样本中对 MacCAT-T 的法语版本进行实证验证。
在这项横断面研究中,我们纳入了来自蒙彼利埃成人精神病学系的 125 名住院精神分裂症患者。由一名经过培训的心理学家对患者进行 MacCAT-T 测试。还对患者的症状严重程度、疾病洞察力、抑郁和焦虑症状进行了评估。还对内部一致性、结构有效性、判别和发散有效性等信度和效度进行了研究。
MacCAT-T 的内部一致性较高(Cronbach α 为 0.91)。MacCAT-T 的所有领域都具有很高的评分者间信度(组内相关系数范围为 0.92 至 0.98)。探索性因子分析显示存在 2 个因子模型。因子分析解释了总评分变化的 50.03%。组成 1 包括“理解”的所有子部分。组成 2 包括“评价”和“推理”的所有子部分,因此被标记为“反思”。经过 Bonferroni 校正后,决策能力与洞察力和精神病症状严重程度呈正相关,但与社会人口学变量无关,除了教育程度。
MacCAT-T 具有很高的评分者间信度和良好的心理测量特性。MacCAT-T 的法语版本是评估法国精神分裂症患者同意治疗决策能力的有效工具。